Welcome to the MDI website. Content and updating of information is ongoing on our website, therefore if you cannot find what you are looking for please contact us.

Getting Ireland’s Adults Covid-Vaccination ready – a public lecture from the Irish Gerontological Society on Wed 17 February from 3.00 – 4.15pm. For more information, follow the link here.

MDI urges Government to prioritise people with muscular dystrophy who are ‘very high risk / extremely medically vulnerable’ and ‘high risk’ from Covid-19 for vaccination, as well as their unpaid/informal carers

MDI has written to key Government ministers and those in opposition, appealing for the prioritisation of people with muscular dystrophy / neuromuscular conditions who are ‘very high risk / extremely medically vulnerable’ and ‘high risk’ from Covid-19 for vaccination, as well as their unpaid / informal carers. You can view our letter to Minister for […]

Updated Frequently Asked Questions about coronavirus (Covid-19) and neurological disease from Adult Neurology Services

Updated Frequently Asked Questions about coronavirus (Covid-19) and neurological disease from Adult Neurology Services MDI wishes to share with you updated Frequently Asked Questions (FAQs) concerning COVID-19 and vaccination from Adult Neurology Services. MDI notes that the FAQs from Adult Neurology Services state that people with chronic neurological conditions such as Muscular Dystrophy, Spinal Muscular […]

Submission to Joint Committee on Disability Matters

  Muscular Dystrophy Ireland is a signatory of a submission made ot the Joint Committee on Disability Matters which calls on the Government to give greater vaccine priority to patients with chronic and/or rare conditions, and to establish a direct line of communication between patient organisation leaders and the Department of Health. You can view […]

COVID-19 Vaccine Information from the HSE

  The HSE has recently issued new information regarding the COVID-19 vaccine. Click the image or link below to read or download the information PDF Further information is available from the HSE website: https://www2.hse.ie/covid-19-vaccine/ COVID-19 Vaccine English  

1. Muscular Dystrophies

  • Becker muscular dystrophy
  • Duchenne muscular dystrophy
  • Manifesting carrier of Duchenne
  • Congenital muscular dystrophy - General
  • • MDC1A (merosin-deficient congenital muscular dystrophy)
  • • Rigid spine syndrome (RSS)
  • • Ullrich congenital muscular dystrophies
  • • Bethlem myopathy
  • Emery-Dreifuss muscular dystrophy

2. Myotonic Disorders

  • Congenital Myotonic Dystrophy
  • Myotonia
  • Myotonic Dystrophy

3. Congenital Myopathies

  • Central Core Myopathy
  • Minicore (Multicore) myopathy
  • Myotubular or Centronuclear myopathy
  • Nemaline myopathy

4. Mitochondrial Myopathies

  • Mitochondrial Myopathies

5. Metabolic Disorders

  • Metabolic disorders (general)
  • McArdle’s Disease
  • Pompe’s Disease

6. Periodic Paralyses

  • Periodic Paralyses

7. Autoimmune Myositides

  • Polymyositis, Dermatomyositis and Sarcoid myopathy
  • Juvenile dermatomyositis
  • Inclusion body myositis

8. Spinal Muscular Atrophies

  • Severe (Type I)
  • Intermediate (Type II)
  • Mild (Type III)
  • Adult spinal muscular atrophy

9. Hereditary Motor and Sensory Neuropathies

  • (Also known as Charcot-Marie-Tooth or Peroneal muscular atrophy)

10. Disorders of the Neuromuscular Junction

  • Congenital myasthenic syndromes
  • Myasthenia Gravis

11. Friedreich’s Ataxia

  • Facioscapulohumeral muscular dystrophy
  • Limb-girdle types of muscular dystrophy (LGMD) - General
  • • LGMD 1B (also known as Laminopathy)
  • • LGMD 1C (also known as Caveolinopathy)
  • • LGMD 2A (also known as Calpainopathy)
  • • LGMD 2B (also known as Dysferlinopathy)
  • • LGMD 2I
  • Ocular myopathies including ocularopharangeal muscular dystrophy

12. Other (Please Specify)

13. Unspecified